Highlights
About
Wearable Electromechanical Insulin Delivery Device
InnoCAT develops a wearable electromechanical device for insulin delivery, designed to simplify diabetes management while improving patient comfort and safety. The company’s proprietary pump architecture integrates user-centric design with efficient electromechanical components to achieve high wearability, usability, and reliability. InnoCAT emphasizes manufacturability and cost efficiency from the outset, ensuring a low cost of goods and scalable production. Its business model is built around profitability through design simplicity and streamlined assembly processes. By partnering with leading medical device manufacturers, InnoCAT aims to deliver a sustainable and commercially viable insulin pump that balances clinical performance with user convenience
Identity
| Name | InnoCAT |
|---|---|
| Slug | innocat |
| Type / kind | startup |
| Source _id | KCe8i33Dcqz8PNYaxGkarvYxiQjWR5rIvSS0w7GNnKfUt2643l4SWJ |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | North District |
| HQ city | Givat Ela |
| HQ address | Neve Eitan St 16, Givat Ela, Israel |
Web & social
| https://www.linkedin.com/company/81941536 |
Classifications
Funding
| Total raised | — |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}